These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 32317860)
1. Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats. Bao N; Dai D Mediators Inflamm; 2020; 2020():2120971. PubMed ID: 32317860 [TBL] [Abstract][Full Text] [Related]
2. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats. Cakir M; Polat A; Tekin S; Vardi N; Taslidere E; Rumeysa Duran Z; Tanbek K Ren Fail; 2015 May; 37(4):704-8. PubMed ID: 25687385 [TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201 [TBL] [Abstract][Full Text] [Related]
4. [Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms]. Xiang BQ; He JB; Gao H; Luo ZY; Dai YY; Wang WT Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):415-419. PubMed ID: 29926585 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats. Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice. Chen Z; Ding T; Ma CG Biochem Biophys Res Commun; 2017 Nov; 493(2):1143-1150. PubMed ID: 28784305 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling. Bao N; Tang B; Wang J J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532 [TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats. Kim SH; Jun JH; Oh JE; Shin EJ; Oh YJ; Choi YS PLoS One; 2018; 13(8):e0198307. PubMed ID: 30114208 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity Zhou BY; Yang J; Luo RR; Sun YL; Zhang HT; Yang AX; Zhang GX Front Biosci (Landmark Ed); 2023 Dec; 28(12):323. PubMed ID: 38179733 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine protects against ischemia-reperfusion injury in rat skeletal muscle. Dong X; Xing Q; Li Y; Han X; Sun L J Surg Res; 2014 Jan; 186(1):240-5. PubMed ID: 24007817 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages. Chen Y; Huang Y; Xiong B; Luo H; Song X Gene; 2020 Oct; 758():144973. PubMed ID: 32707303 [TBL] [Abstract][Full Text] [Related]
12. [Effect of dexmedetomidine on renal injury induced by lung ischemia/reperfusion in mice]. Xiang BQ; Gao H; Luo ZY; Fang ZX; Wang WT Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):380-384. PubMed ID: 29926648 [TBL] [Abstract][Full Text] [Related]
13. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture. Kiyonaga N; Moriyama T; Kanmura Y Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689 [TBL] [Abstract][Full Text] [Related]
14. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney? Erkılıç E; Kesimci E; Alaybeyoğlu F; Kılınç I; Tural R; Yazgan A; Gümüş T; Sepici Dinçel A; Dumlu EG; Kanbak O Drug Des Devel Ther; 2017; 11():677-683. PubMed ID: 28331287 [TBL] [Abstract][Full Text] [Related]
15. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study. Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237 [TBL] [Abstract][Full Text] [Related]
17. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway. Zhang J; Jiang H; Liu DH; Wang GN Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917 [TBL] [Abstract][Full Text] [Related]
18. Perioperative acute kidney injury: The renoprotective effect and mechanism of dexmedetomidine. Gao X; Wu Y Biochem Biophys Res Commun; 2024 Feb; 695():149402. PubMed ID: 38159412 [TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK. Wang Z; Zhou W; Dong H; Ma X; He Z Mol Med Rep; 2018 Oct; 18(4):3957-3964. PubMed ID: 30106098 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway. Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]